Batch Notification Number |
BN-OL-2022-09-12-4681
|
FDA Registered Product/Generic Name |
Co-Amoxiclav
|
Brand Name |
Co-Amoxisaph-250
|
Dosage Strength |
250 mg/ 62.5 mg per 5 mL
|
Dosage Form |
Powder for Oral Suspension
|
Registration Number |
DRP-8398
|
Batch Number |
NXF 25
|
Lot Number |
N/A
|
Product Expiration Date |
07/2023
|
Issuance Date |
19 September 2022
|